Divis Laboratories Ltd reported 3.4B in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 845K 162K Dec/2024
Aurobindo Pharma INR 11.63B 310.9M Mar/2025
Avita Medical AUD 21.23M 2.57M Dec/2024
Dianthus Therapeutics USD 8.87M 2.04M Jun/2025
Divis Laboratories Ltd 3.4B 10M Jun/2025
Ionis Pharmaceuticals USD 90.6M 14.6M Jun/2025
IQVIA Holdings USD 509M 1000K Jun/2025
Lupin INR 10.83B 817.5M Jun/2025
Moderna USD 230M 18M Jun/2025
Organon & Co USD 453M 33M Jun/2025
Revvity USD 248.53M 1.19M Jun/2025
Tectonic Therapeutic USD 5.15M 315K Jun/2025
Tilray USD 72.38M 4.99M Nov/2024
Viatris USD 928.7M 111.2M Jun/2025
Xeris Pharmaceuticals USD 44.39M 35.89M Jun/2025